Oncogene withdrawal engages the immune system to induce sustained cancer regression. - Wikidata - awgldk - TriplyDB

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

http://www.wikidata.org/entity/Q33987633

about

Targeting cancer with kinase inhibitors EZH2 as a mediator of treatment resistance in melanoma Designing a broad-spectrum integrative approach for cancer prevention and treatment.Cancer prevention and therapy through the modulation of the tumor microenvironment.Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.MYC: Master Regulator of Immune Privilege.Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.The MYC oncogene is a global regulator of the immune response.The distinct roles of mesenchymal stem cells in the initial and progressive stage of hepatocarcinoma.

P2860

Q26865765-9A63D007-2A09-4C7D-908E-5DC5ACA5FE96 Q28074492-49A34627-BBF4-43DC-BAAF-4E89981DF7B0 Q30736359-855A4833-6FE9-4C0F-9DF9-6D05BA451006 Q37058267-D5828108-064D-43FF-B3E5-E91508781378 Q38759115-88734E8D-61E8-4C37-B9CE-D294DB3BCB8C Q39149130-40F25914-15EC-4D04-9D96-4DB6F97E0819 Q39540220-801279DB-D419-47B8-9144-7BF24CFE8F97 Q52728139-FECD63CF-1883-4F97-9740-563FDCC80E74 Q54263670-5055FF1C-0B0B-42C7-88B5-545C907F2FBC

P2860

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

http://www.wikidata.org/entity/Q33987633

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@ast

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@en

type

label

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@ast

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@en

prefLabel

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@ast

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@en

P1433

Q33987633-1F60E777-45DF-4BC7-B5DA-02FD7D51EF50

P1476

Q33987633-EC071FC3-148A-4168-A58E-D0901F7DD276

P2093

Q33987633-4BCC018B-FD6B-4C2C-B313-47C5A8EC89C2

Q33987633-59999731-36D5-4329-8B4D-07998AF9B396

Q33987633-A966076F-FC63-4F3F-A680-5BB87E27A8FD

Q33987633-D67F9EE7-7228-47DC-BDBC-350D1BC8E21D

P2860

Q33987633-00E4DD4A-F5C2-4584-8585-DE952C3ECE30

Q33987633-01B31EEB-E1E6-4A0E-A271-A95FB8C2A569

Q33987633-03457BE2-7B9F-4845-B2B8-0028AD899CFD

Q33987633-077761A4-0849-4718-928E-1010F20E50ED

Q33987633-09D8B679-C0B5-421B-B9D1-F4959B633F3D

Q33987633-0A313B52-732B-49C2-8672-72A753521C4F

Q33987633-0CF18C67-F189-4A98-8597-2B51AE4CF7AB

Q33987633-0DB6496A-5DCB-4B20-BFDD-DCD4E7C515E2

Q33987633-0E782DCB-B529-4D0C-9FAB-27C139E96B8B

Q33987633-10CCBBD9-C01D-46C4-B3A7-C868F9909E6B

P2888

Q33987633-B04CECB2-6758-4F84-916F-9E2AB30F898D

P304

Q33987633-8426FEFA-3C74-4BE7-8F40-C83251620973

P31

Q33987633-A4D5608A-95E0-4C32-ABEE-51A33932D49C

P356

Q33987633-A23445A2-4D3E-4874-AEFD-9A8C60558977

P478

Q33987633-A4F4C577-22FC-4548-9B75-C282032C0E50

P577

Q33987633-A0459626-BDD9-4842-82D1-D75C9D71D9A1

P5875

Q33987633-F5713291-333F-42B5-8930-B95D3C1F40D2

P6179

Q33987633-0EDB2E8C-532B-4F38-BB96-66ED48FFDA04

P698

Q33987633-17931481-0A66-43DF-B6CB-E7D79CCF0079

P932

Q33987633-B5582C0B-D60E-4AB0-9CC4-1F74999D80A1

P356

P1433

Journal for Immunotherapy of Cancer

P1476

Oncogene withdrawal engages the immune system to induce sustained cancer regression.

@en

P2093

Alice C Fan

http://www.w3.org/2001/XMLSchema#string

Dean W Felsher

http://www.w3.org/2001/XMLSchema#string

Stephanie C Casey

http://www.w3.org/2001/XMLSchema#string

Yulin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Aids-related malignancies

Hallmarks of Cancer: The Next Generation

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

The genomic landscapes of human breast and colorectal cancers

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.

Putting tumours in context

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

Cancer despite immunosurveillance: immunoselection and immunosubversion

P2888

P304

24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2051-1426-2-24

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264463037

http://www.w3.org/2001/XMLSchema#string

P6179

1016335969

http://www.w3.org/2001/XMLSchema#string

P698

25089198

http://www.w3.org/2001/XMLSchema#string

P932

4118610

http://www.w3.org/2001/XMLSchema#string